]>
IRCT20150817023666N11 IRCT 2018-04-09 Iran University of Medical Sciences the Effect of intraperitoneal Bupivacaine in pain reduce the Effect of intraperitoneal Bupivacaine in comparison with Dexmedetomidine with Bupivacaine Spray on pain reduction after laparoscopic Endometrial Surgery, A Randomized Clinical Trial 2016-03-20 anticipated 45 Complete https://irct.ir/trial/20176 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly assigned to three groups of 15 people, using the random numbers table, Blinding description: Participants and outcome evaluators will not be informed of random allocation. For this purpose, before the random allocation, a full explanation of the intervention was given to the patient, Patients will not be informed about random allocation. The outcome evaluators will not be aware of the allocation of patients to study groups. 2-3 Endometriosis. Intervention 1: First group: intra peritonal bupivacaein spray ( 50 cc 0.25%) this intervention will be performed at the end of the procedure. Intervention 2: second group: intraperitonal bupivacaein( 50 cc .25% )with DEX(1 micro g/kg) spray this intervention will be performed at the end of the procedure. Intervention 3: control group: intraperitonal normalsalin spray this intervention will be performed at the end of the procedure. Yes - There is a plan to make this available What will be shared: Total data without personal information When: after publication of paper To whom: Researchers Conditions: further research Where to obtain: Dr.Rokhgireh s.rokhgireh@gmail.com How to obtain: Request via E-male Comments:
public Zahra Najmi
Niayesh Av, Sattar khan st, Tehran, Iran
Tehran Iran (Islamic Republic of) 1449613131 +98 21 6650 9283 amehdizadehkashi@yahoo.com Iran University of Medical Sciences scientific Abolfazl Mehdizadeh Kashi
Niayesh Av. Sattar khan st. Tehran, Iran.
Tehran Iran (Islamic Republic of) 1449613131 +98 21 6650 9283 amehdizadehkashi@yahoo.com Iran University of Medical Sciences Iran (Islamic Republic of) Informed consent to enter the study Candidate for laparoscopic surgery due to benign gynecological disease Age between 20 and 65 years Patients ASA I, II women with endometriosis 20 years 65 years Female Patients who have not signed the consent form Patients whose laparoscopic surgery has changed to vaginal or abdominal Patients that underwent surgery without general anesthesia Pregnant women Allergy to local anesthetics or Dexmedetomidine Patients with morbid obesity Patients with liver or kidney failure N80.0 Endometriosis of uterus Treatment - Drugs Treatment - Drugs Treatment - Drugs First group: intra peritonal bupivacaein spray ( 50 cc 0.25%) this intervention will be performed at the end of the procedure. second group: intraperitonal bupivacaein( 50 cc .25% )with DEX(1 micro g/kg) spray this intervention will be performed at the end of the procedure control group: intraperitonal normalsalin spray this intervention will be performed at the end of the procedure. Pain. Timepoint: before surgery and 2,4 ,6 ,12 and 24 Hour after surgery. Method of measurement: Visual analog score. Iran University of Medical Sciences Approved 2016-09-14 Ethic commite of Iran University of Medical science Next to Milad Tower, Hemmat hayway, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)